PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University of Oxford, Oxford, United Kingdom.\', \'Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, Netherlands.\', \'Transfusion Research Centre, Belgian Red Cross-Flanders, Ghent, Belgium.\', \'Department of Pathology, Faculty of Veterinary Medicine, Liège University, Liège, Belgium.\', \'Immune Response service, Sciensano, Brussels, Belgium.\', \'National Influenza Centre, Sciensano, Brussels, Belgium.\', \'KU Leuven, Rega Institute, Clinical and Epidemiological Virology, Leuven, Belgium.\', \'Vircell SL, Granada, Spain.\', \'Andalusian Network of Transfusion Medicine, Tissues and Cells, Sevilla, Spain.\', \'Virus and Microbiological Special Diagnostics, Statens Serum Institute, Copenhagen, Denmark.\', \'Tartu University Institute of Technology, Tartu, Estonia.\', \'Institute of Microbiology and Immunology, Ljubljana, Slovenia.\', \'Centre for Infectious Disease Control, WHO COVID-19 Reference Laboratory, RIVML, Bilthoven, the Netherlands.\', \'Dep. of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway.\', \'Etablissement Français du Sang, La Plaine Saint Denis, France.\', \'Unité des Virus Émergents (Aix-Marseille University - IRD 190 - Inserm 1207 - IHU Méditerranée Infection), Marseille, France.\', \'Etablissement français du Sang Provence Alpes Côte d\'Azur et Corse, Marseille, France.\', \'Centre de Transfusion Sanguine des Armées, Clamart, France.\', \'Unité de Virologie, Institut de Recherche Biomédicale des Armées, Marseille, France.\', \'Department of Transfusion Medicine, Ulm University, Ulm, Germany.\', \'Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-Wurttemberg - Hessen and University Hospital Ulm, Ulm, Germany.\', \'Microbiology Services, NHS Blood and Transplant, Colindale, United Kingdom.\', \'University College of London, London, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.2807/1560-7917.ES.2021.26.27.2100568
?:doi
?:hasPublicationType
?:journal
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
is ?:pmid of
?:pmid
?:pmid
  • 34240697
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34240697>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34240697>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all